Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the dengvaxia market right now?

Over the past few years, the dengvaxia market has seen a quick expansion. Its size, projected to upscale from $181.23 million in 2024 to $213.36 million in 2025, will experience a compound annual growth rate (CAGR) of 17.7%. This significant progression during the historical period is due to factors such as health-related policies initiated by the government, increased consciousness about public health, the urgency of preventive actions, a rise in dengue cases associated with travel and advancements in healthcare infrastructure.

How fast Is the dengvaxia market expected to grow, and what’s its future value?

The market size of dengvaxia is predicted to experience swift expansion in the coming years. Degnvaxia’s value will surmount to $404.70 million in 2029, with a compound annual growth rate (CAGR) of 17.4%. Factors contributing to this growth in the predicted period include the escalation of dengue outbreaks, augmented government support, partnerships among public and private sectors, increasing public cognizance regarding dengue prevention, and improved health care systems. Noteworthy trends during this forecast period encompass progression in vaccine technology, continuous research and development efforts, novel innovations in vaccine delivery techniques, creation of new vaccine formulas, and enhanced methods of vaccine storage and distribution.

Get your dengvaxia market report here!

https://www.thebusinessresearchcompany.com/report/dengvaxia-global-market-report

What are the leading drivers of growth in the dengvaxia market?

The rise in dengue cases is predicted to drive the expansion of the dengvaxia market. Dengue, a virus carried by Aedes mosquitoes, induces symptoms similar to flu, intense pain, and in extreme instances, can result in potentially fatal conditions like dengue hemorrhagic fever or dengue shock syndrome. Factors such as climate change, urbanization, increased global travel, and the spread of mosquito breeding sites have led to higher rates of dengue infection, thereby resulting in a higher need for prevention and treatment strategies. With its ability to invigorate the immune system to create a defensive reaction against the dengue virus, Dengvaxia aids in preventing dengue. This reduces the risk of infection and severe health complications, and contributes to better public health results in regions where dengue is prevalent. Indeed, in June 2024, the Centers for Disease Control and Prevention (CDC), a US governmental agency, disclosed that there were more than 9.7 million dengue cases in the Americas, which is more than double the 4.6 million cases recorded in 2023. A public health crisis was declared in Puerto Rico following 1,498 registered cases, and another 745 cases were reported among U.S. travellers. This explains why the rising incidences of dengue stand as a major growth driver for the dengvaxia market.

What are the key segments defining the dengvaxia market?

The dengvaxia market covered in this report is segmented –

1) By Type: Dengvaxia, Other Types

2) By Distribution Channel: Hospitals, Clinics, Public Health Programs

3) By Clinical Indication: Prevention In Previously Infected Individuals, Protection In High-Risk Regions, Traveler Immunization, Pediatric And Adolescent Use

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20035&type=smp

Who are the key players steering the development of the dengvaxia market?

Major companies operating in the dengvaxia market include Sanofi Pasteur Inc.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20035

Which regions are most influential in expanding the dengvaxia market?

Asia-Pacific was the largest region in the dengvaxia market in 2024. Latin America is expected to be the fastest-growing region in the forecast period. The regions covered in the dengvaxia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Yellow Fever Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Influenza A Virus Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/h1n1-vaccine-global-market-report

Typhoid Vi Polysaccharide Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/typhoid-vi-polysaccharide-vaccine-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: